The pro-FEIBA study: prophylactic dosing of Factor Eight Inhibitor Bypassing Activity (FEIBA) reduces bleeding frequency in haemophilia a patients with inhibitors

Gringeri A., Antmen B., Berntorp E., Biasioli C., Carpenter S., Kavakli K., ...More

HAEMOPHILIA, vol.17, pp.363, 2011 (Journal Indexed in SCI) identifier

  • Publication Type: Article / Abstract
  • Volume: 17 Issue: 2
  • Publication Date: 2011
  • Title of Journal : HAEMOPHILIA
  • Page Numbers: pp.363